[1]
2023. Differentiation Syndrome and Early Mortality in Patients with Acute Promyelocytic Leukemia (APL) Treated with All-Trans Retinoic Acid. Annals of Leukemia Research. 4, 1 (Aug. 2023), 7–12. DOI:https://doi.org/10.5281/zenodo.22213697.